NCT06467630

Brief Summary

The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

February 9, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

2.2 years

First QC Date

January 2, 2024

Last Update Submit

April 30, 2026

Conditions

Keywords

Guided Bone RegenerationDental surgical procedures

Outcome Measures

Primary Outcomes (1)

  • Post-operative wound healing measured by the Early Wound-Healing Index

    For all groups The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 3 (late post-surgery follow-up) for the primary outcome measure.

    up to 6 months

Secondary Outcomes (7)

  • Post-operative wound healing measured by Early Wound-Healing Index

    up to 14 days

  • Post-operative wound healing measured by Early Wound Healing Score

    up to 14 days

  • Post-operative clinical exam

    up to 6 months

  • Number of adverse device effects (at least possibly) related to study device

    up to 6 months

  • Oral Health-Related Quality of Life measured by the Oral Health Impact Profile (OHIP-5 items)

    up to 6 months

  • +2 more secondary outcomes

Study Arms (3)

Post-extraction socket preservation group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Post-extraction socket preservation (not done concomitantly to implant placement).

Procedure: Preserving alveolar bone volume after tooth extraction

Alveolar ridge augmentation group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Alveolar ridge augmentation (not done concomitantly to implant placement).

Procedure: Alveolar crest reconstruction

Guided Tissue Regeneration (GTR) during immediate implant placement group

The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Guided Tissue Regeneration (GTR) during immediate implant placement

Procedure: Covering bone defects during immediate implant placement.

Interventions

* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * V2bis (1 month +/- 1 week) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Post-extraction socket preservation group

* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up

Alveolar ridge augmentation group

* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement. * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (3 months ± 1 month) - Late post-surgery follow-up

Guided Tissue Regeneration (GTR) during immediate implant placement group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eligible patients are any male and female, adult patients with one of the 3 following dental treatments to be done with the study device: * post-extraction socket preservation\*, * alveolar ridge augmentation\*, * Guided Tissue Regeneration (GTR) during immediate implant placement. The dental treatment under investigation for one patient could be related to: * 1 alveolar socket corresponding to only 1 tooth; * 1 implant to be placed in replacement of 1 tooth; * several contiguous alveolar sockets; * Or, several contiguous implants to be placed. Dental treatments done simultaneously in non-contiguous dental zones won't be considered for this study.

You may qualify if:

  • Male or female adult patient
  • Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement.
  • Patient affiliated or beneficiary of a social security system.
  • Patient has signed his/her informed consent form.

You may not qualify if:

  • Pregnancy or lactation
  • Active tissue infection at the implant site
  • Several dental treatments done simultaneously in non-contiguous dental zones
  • Heavy smoker (\>10 cigarettes / day)
  • Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head \& neck radiotherapy or chemotherapy
  • Patient with chronic infections (such as osteomyelitis) at the surgical site
  • Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders)
  • Patient with an auto-immune disease
  • Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Hospital University of Nantes

Nantes, 44000, France

Location

Private dental practice office of Dr. Alain Hoornaert

Nantes, 44000, France

Location

Private dental practice office of Dr. Samer Saloum-Rouxel

Nantes, 44000, France

Location

Private dental practice office of Dr. Xavier Struillou

Nantes, 44000, France

Location

Private dental practice office of Dr. Edouard Lanoiselée

Nozay, 44170, France

Location

Private dental practice office of Dr. Aurélien Fruchet

Olonne-sur-Mer, 85340, France

Location

Private dental practice office of Dr. Hélène Le Hécho

Orée d'Anjou, 49530, France

Location

Private dental practice office of Dr. Nicolas Strube

Orvault, 44700, France

Location

Private dental practice office of Dr. Romain Besnier

Orvault, 44700, France

Location

Study Officials

  • Alain Hoornaert, DDS

    University Hospital of Nantes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2024

First Posted

June 21, 2024

Study Start

February 9, 2024

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations